RxDoctor Payments Data

Eileen Diaz Cabrera

General Practice · Trujillo Alto, PRNPI 1902801822

Payments from drug & device makers

$4,744in general payments, 2019–2025

Across 194 payments — averaging $24.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Boehringer Ingelheim$836
  • Johnson & Johnson$770
  • PBG Puerto Rico LLC$332
  • Sanofi-aventis U.S. LLC$303
  • Merck$270
  • plus $715 from 10 others

What the payments were for

  • Food & beverage$4,722100%
  • Education$220%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,744 in reported general payments places this provider in the 95th percentile of 3,586 general practice providers in Puerto Rico.

See all general practice providers in Puerto Rico

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanumetSitagliptin Phos/Metformin Hcl71$72,567
FarxigaDapagliflozin Propanediol87$67,439
JardianceEmpagliflozin84$63,438
JanuviaSitagliptin Phosphate74$55,468
EliquisApixaban50$39,767
SynthroidLevothyroxine Sodium594$36,974
TrulicityDulaglutide27$28,755
Janumet XrSitagliptin Phos/Metformin Hcl46$21,567
Trijardy XrEmpaglifloz/Linaglip/Metformin30$19,832
Synjardy XrEmpagliflozin/Metformin Hcl20$15,636
Breo ElliptaFluticasone/Vilanterol20$8,302
Candesartan Cilexetil101$8,068
SynjardyEmpagliflozin/Metformin Hcl13$8,045
LantusInsulin Glargine,hum.Rec.Anlog41$6,354
Candesartan-HydrochlorothiazidCandesartan/Hydrochlorothiazid54$5,269

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanumet, Januvia, Janumet Xr$270$149,602191 claims
Boehringer IngelheimJardiance, Trijardy Xr, Synjardy Xr, Synjardy$836$106,950147 claims
AstraZenecaFarxiga$1,516$67,43987 claims
PfizerEliquis$5$39,76750 claims
AbbVieSynthroid$20$36,974594 claims
Lilly USA, LLCTrulicity, Humulin 70-30, Humulin N$237$32,68067 claims
Sanofi-aventis U.S. LLCLantus$303$6,35441 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,586 general practice providers in Puerto Rico.

Other general practice in Trujillo Alto

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →